Hi there!

I’m making a difference and running 12km in October for a cause that’s close to my heart. My girlfriend has recently started treatment for Lupus and has battled with several of its symptoms for the past 7 years. With this, we no longer need to keep searching for answers and can start treating and improving quality of life. In light of this, we would like to spread awareness on Lupus and support our local association. Please support our efforts by making a secure online donation and by posting a message of support. No amount is too big or too small.

Donations made through this platform are secure and will be remitted directly through to my charity of choice.

This would mean so much to her and I hope we can make that happen. Please find the link to our fundraiser page here;


Phase 3 Trial Finds Benlysta Significantly Improves Kidney Response in People with Lupus Nephritis

UPDATE 16/09/2020

In new results on the international phase 3 clinical trial (BLISS-LN) of the drug Benlysta (belimumab), researchers found that Benlysta reduced the risk of worsening kidney function during the study by almost 50%, compared with standard therapy alone.

The groundbreaking results from the phase 3 BLISS-LN clinical trial could lead to Benlysta becoming the first drug approved by the Food and Drug Administration (FDA) (United States of America) to treat lupus nephritis, the most common severe complication of SLE that could lead to end-stage kidney disease and death.

Read the Study

Raise a hand to help us

Help research to find a cure!

Join us as we work to find a cure for this hidden monster

Coronavius (COVID-19)

For the latest  information available on this topic, please use the following link to the Australian Government Department of Health.

If you would like to get in contact with us concerning this issue please either:

Phone: (02) 9878 6055 or
Email: info@lupusaust.org.au



Read More >


Better Living

Read More >


Global Lupus

Read More >



Read More >


Show You Care

Read More >


Helping Others

Read More >